SCHEMBL8904646

SCHEMBL8904646

CCC(=O)OC1=C(C)OC(CC)C1=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.32
TSHR P16473 1/20 0.32
HTT P42858 1/20 0.32
KDM4E B2RXH2 3/20 0.32
ALDH1A1 P00352 2/20 0.32
ELANE P08246 1/20 0.32
KMT2A Q03164 3/20 0.31
GLA P06280 2/20 0.31
GAA P10253 2/20 0.31
HPGD P15428 2/20 0.31
MAPK1 P28482 2/20 0.31
HSD17B10 Q99714 2/20 0.31
LMNA P02545 1/20 0.31
ESR1 P03372 1/20 0.31
RECQL P46063 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
HIF1A Q16665 1/20 0.31
ACHE P22303 1/20 0.30
USP2 O75604 1/20 0.30
CASP1 P29466 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8904127 0.87 KMT2A (0.36) MAPTTSHRHTTKDM4EALDH1A1
SCHEMBL8904595 0.86 CYP1A2 (0.32) MAPTTSHRHTT
SCHEMBL8904128 0.85 MAPT (0.33) MAPTTSHRHTTALDH1A1HSD17B10
SCHEMBL8905714 0.84 ALDH1A1 (0.35) MAPTTSHRHTTALDH1A1
SCHEMBL8905063 0.84 RECQL (0.38) MAPTKDM4EKMT2ARECQLSMN1; SMN2
SCHEMBL8905920 0.83 PRKCA (0.39) MAPTRECQL
SCHEMBL8905344 0.82 PRKCA (0.41) MAPTRECQL
SCHEMBL8905907 0.82 PRKCA (0.41) MAPTRECQL
SCHEMBL8906517 0.82 PRKCA (0.41) MAPTRECQL
SCHEMBL8905186 0.82 PRKCA (0.41) MAPTRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5698585-A FOR SENILE CATARACT CAUSED BY OXIDATION DISORDER; VISION DEFECTS KIKKOMAN CORPORATION (JP) 1997-12-16 US disclosed
EP-0737476-A2 A pharmaceutical preparation containing a 3-(2H)-furanone derivative for prevention and/or treatment of cataracts KIKKOMAN CORPORATION (JP) 1996-10-16 EP disclosed